Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates for central nervous system disorders, with worldwide commercial rights to two product candidates in clinical development. The Company's product portfolio includes Iloperidone, a compound for the treatment of schizophrenia and Tasimelteon, a compound for the treatment of sleep and mood disorders, including circadian rhythm sleep disorders (CRSD).
There are no scholarships at this time
There are no events at this time
Company Data on
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is hiring for these positions